Malignant Skin Neoplasm — Trials

Malignant Skin Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 320
Recruiting: 171
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (202)

clinicaltrialsPublishedShowing 51–61 of 61 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05565417	Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas	active not recruiting	Phase 1 / Phase 2	67	Immunitas TherapeuticsINDUSTRY	1	Oct 16, 2025	clinicaltrials
NCT06715592	ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study	active not recruiting	Phase 2	18	Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER	1	Aug 8, 2025	clinicaltrials